Development and evaluation of an interactive web-based decision-making programme on relapse management for people with multiple sclerosis (POWER@MS2)-study protocol for a randomised controlled trial.

Anne Christin RahnLisa WenzelAndrea IcksAlexander StahmannJutta ScheiderbauerKristina GrentzenbergMarkus VomhofJoseph MontalboTim FriedeChristoph HeesenSascha Köpke

Published in: Trials (2021)

ClinicalTrials.gov NCT04233970 . Registered on 18 January 2020.

Keyphrases

multiple sclerosis
decision making
white matter
mass spectrometry
study protocol
ms ms
free survival
randomized controlled trial
clinical trial